Michael L. Parchman, MD1 Amer Kassai, PhD2 Jacqueline A. Pugh, MD1

Slides:



Advertisements
Similar presentations
Management of Diabetes Treat to Target Approach (A1c
Advertisements

Today’s Agenda Discuss the prevention and management of cardiovascular complications of diabetes Mention the other complications along with prevention.
Investigating Gender Differences in HEDIS Measures Related to Heart Disease Ann F. Chou, PhD, MPH Carol S. Weisman, PhD Rosaly Correa-de-Araujo, MD, PhD.
Sandra G. Adams, MD, MS Pulmonary Diseases / Critical Care Medicine University of Texas Health Science Center at San Antonio South Texas Veterans Healthcare.
NW PA Data Review Robert A. Gabbay, MD, PhD Professor of Medicine, Penn State College of Medicine.
Frank Svec, MD, PhD Clinical Professor of Medicine Tulane University School of Medicine New Orleans, Louisiana Kevan Chambers Announcer Medscape Diabetes.
Topics John Parmer, PhD Health Communication Specialist Centers for Disease Control and Prevention 1) What is Health Literacy? 2) National Action Plan.
Overview of the CVD Risk Reduction Demonstration Project Kelly Acton, MD, MPH, FACP IHS Division of Diabetes Treatment & Prevention.
® Introduction The Skinny on Obesity in Texas: BMI in Texas Family Medicine Clinics Kristin M. Yeung, Ramin Poursani, MD, Sandra K. Burge, PhD The University.
The Great Diabetes Epidemic: A Manifesto for Action.
WHI Extension New Directions for Environmental Studies in the Women’s Health Initiative Annual WHI Investigator Meeting Washington, DC Friday.
Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome Featured Article: G. Neil Thomas, Ph.D.,
The Global Burden of Diabetes Dr. Naeem Zahid MD, PhD, MBA.
Public Health. CVDDiabetesCancer Antibiotic Resistance.
Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:
Wellness and the Allied Health Professions Raul Caetano, M.D., Ph.D.
Unit 11 Power Notes – Part 1 Science, Technology and Medicine in the mid to late 20 th century (Chapter 24-26)
Problem: Although over 80% of all physician visits by adults with type 2 diabetes are to primary care physicians, little is known about the content of.
THE COMMONWEALTH FUND Source: McCarthy and Leatherman, Performance Snapshots, Percentage of Community-Dwelling Adults Ages.
Michael Parchman, MD, MPH Walter Calmbach, MD, MPH Marisa Rodriguez, BS UT Health Science Center at San Antonio South Texas Ambulatory Research Network.
中国农村心血管病防治面临的挑战 Challenges in prevention and control of CVD in Rural China Yangfeng Wu, MD, PhD The George Institute for Global Health at Peking University.
Problem: Studies suggest that primary care physician-patient encounters are characterized by competing demands that force clinicians to prioritize and.
Stretching Scarce Resources: State Strategies to Design Effective, Affordable Benefit Packages Autumn Dawn Galbreath, M.D. Director University of Texas.
Are efforts to improve technical quality of care competing with improving clinical outcomes?: The case of the elevated A1c Parchman ML, Pugh JA, Romero.
Medical Technology Essential Questions:
Oral Health and Diabetes: A Two Way Street Maria Emanuel Ryan D.D.S., Ph.D. Professor of Oral Biology and Pathology Associate Dean of Strategic Planning.
Practice Transformation for Physicians and Health Care Teams
Coordination of Care, Information Support, and Quality of Diabetes Care : A STARNet Study Michael L. Parchman, MD, MPH Raquel L. Romero, MD Jacqueline.
Vitamin D: A New Frontier in Diabetes Management Contact Information: Background Acknowledgement Methods.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Measures of Hyperglycemia Random plasma glucose (RPG)—without regard to time of last meal Fasting plasma glucose (FPG)—before breakfast Oral glucose tolerance.
Michael L. Parchman, MD1 Jacqueline A. Pugh, MD2 Raquel L. Romero, MD1
Michael L. Parchman, MD, MPH
Bonnie T. Jortberg, MS, RD, CDE David Gaspar, MD
How Available is Health Care?
Promoting Health and Wellness in the Workplace: A Unique Opportunity to Establish Primary and Extended Secondary Cardiovascular Risk Reduction Programs 
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
A Novel Approach to Cardiovascular Health By Optimizing Risk Management (ANCHOR): Behavioural Modification in Primary Care Effectively Reduces Global.
Aspirin Use Among U.S. Adults
The Diabetes Shared Care Program and Risks of Cardiovascular Events in Type 2 Diabetes  Edy Kornelius, MD, Jeng-Yuan Chiou, PhD, Yi-Sun Yang, PhD, MD,
Diabetic Dyslipidemia in Practice
Dr.farahani MD-Mph Arak health center
Hemoglobin A1c Targets for Glycemic Controls
Aruna D. Pradhan, MD, Nader Rifai, PhD, Julie E. Buring, ScD, Paul M
Effects of Hypertension, Diabetes, and/or Cardiovascular Disease on Health-related Quality of Life in Elderly Korean Individuals: A Population-based Cross-sectional.
مرکز بهداشت شهرستان اراک انواع بيماريها و اختلالات رواني –عصبي
Diabetes Increases Risk of CVD
Effects of Self-care Health Behaviors on Quality of Life Mediated by Cardiovascular Risk Factors Among Individuals with Coronary Artery Disease: A Structural.
Multilevel Barriers to Optimizing Care in Underserved Women
Increasing Value Through Community-Based Research
2008 FDA Guidance. Working as a Team for Cardiovascular Risk Reduction in Patients With T2D.
Acute Acalculous Cholecystitis: A Review
Promoting Health and Wellness in the Workplace: A Unique Opportunity to Establish Primary and Extended Secondary Cardiovascular Risk Reduction Programs 
Diabetes and Cardiovascular Disease Risk: The Hard Truth
Diabetes and Cardiovascular Disease Risk: The Hard Truth
عوامل اجتماعی موثر بر سلامت
New CHEST Editorial Board Members
Health Care Use and Associated Time and Out of Pocket Expenditures for Patients With Cardiovascular Disease in a Publicly Funded Health Care System  Saba.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
The lord of the rings  Antonio Miceli, MD, PhD 
Child Care Center in San Antonio | Discovery World Learning Center
Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease  Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,
Kaplan-Meier plot of incident CVD according to the treatment group over a 4-year period following intensification of diabetes therapy. Kaplan-Meier plot.
Images in Emergency Medicine
Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia  Martine Paquette, MSc, Sophie.
Baseline predictors of acute complication of diabetes among immigrants with language barriers (N = 87,707). *Adjustment for all variables listed, as well.
Baseline predictors for risk of cardiovascular events or all-cause mortality among immigrants with language barriers (N = 87,707). *Adjustment for all.
Pre-K Classes in San Antonio | Pre-K San Antonio | Discovery World Learning Center
Meta-analysis of trials examining the effects of aspirin on risk of CVD events in patients with diabetes. Meta-analysis of trials examining the effects.
Prevalence of nephropathy, retinopathy, and neuropathy in subjects achieving all (A) three targets, (B) two targets, (C) one target, and (D) none, and.
Presentation transcript:

Cardiovascular Risk Factors, Type 2 Diabetes & Primary Care Clinic Structure Michael L. Parchman, MD1 Amer Kassai, PhD2 Jacqueline A. Pugh, MD1 Raquel L. Romero, MD1 1University of Texas Health Science Center, San Antonio, Texas 2Trinity University, San Antonio, Texas

Cardiovascular Disease (CVD) Risk Factors Glucose Control Hemoglobin A1c Goal: <= 7.0% Blood Pressure Goal: <= 130/80 Lipids LDL Cholesterol Goal: <= 100 mg/dl (if no CAD)

Self-Care Activities Diet, Exercise, Glucose Monitoring, Medication Adherence 5 Stages of Change: Pre-contemplation Contemplation Preparation Action Maintenance: adherence for 6 months or more

The Chronic Care Model (CCM)

Purpose Examine the relationship between control of CVD risk factors, patient self-care behaviors, and the presence of the CCM model elements across a diverse group of primary care clinic settings.

Methods 20 small autonomous primary care clinics Solo practice physicians (n=11) Small group practices (n=3) Community Health Clinic (n=1) VHA Primary Care OPC (n=2) City/County Indigent Health Clinics (n=3) Recruited from a Primary Care Practice Based Research Network (PBRN)

Subjects and Data Collection Patients 30 consecutive presenting pts with an established dx of type 2 DM Exit survey: demographics, stage of change for self-care behaviors, health status (excellent, v. good, good, fair, poor) Chart Abstraction: most recent values of A1c, BP and LDL-cholesterol Clinicians Assessment of Chronic Illness Care (ACIC) Survey. (Bonomi, Wagner et al 2002) (25 items)

ACIC Survey: Sub-Scales Organizational Leadership Community Linkages Self-Management Support Decision Support Delivery System Design Clinical Information Systems

Analysis Outcome: All 3 risk factors well controlled (Y/N) Hierarchical Logistic Model (Random Effects Model) Patients clustered within clinic Predictors: Patient: Age (years) Hispanic ethnicity (Y/N) Female gender Maintenance Stage of Change for all 4 behaviors (Y/N) Clinic Sub-scale scores from ACIC survey

Results: Patient Characteristics Age 58.6 (12.93) Female 51% Hispanic 57% Maintenance Stage of change for all 4 self-care behaviors? 25%

Results: CVD Risk Factors Percent of total (range by clinic) A1c <= 7.0% 43% (20 to 69.7) BP <= 130/80 49% (0 to 72.7) LDL <= 100 50% (0 to 73.3) All 3 well controlled 13% (0 to 31.3)

ACIC Sub-scale Scores Mean (S.D.) Range* Orgnzn Leadership 6.5 (2.3) 2.5 – 10.0 Comm Linkage 7.1 (1.7) 4.3 – 10.7 Self-Care Support 6.9 (1.9) 2.8 – 10.3 Decision Support 6.0 (1.8) 2.7 – 9.0 Delivery System 6.7 (2.2) 3.4 – 11.0 Clinical Info System 5.2 (2.4) 0.6 – 10.2 *Potential Range of each sub-scale: 0 to 11

HLM Model: No Clinic-level Predictors Patient Characteristic Odds Ratio 95% C.I. Age 1.01 1.00, 1.02 Female 0.66* 0.48, 0.92 Hispanic 0.86 0.62, 1.19 All Maintenance 1.55* 1.09, 2.21

HLM: No Patient-level predictors CCM component O.R. 95% C.I. Org Leader 0.89 0.72, 1.11 Comm Linkage 1.65* 1.31, 2.09 Self-Care Support 0.97 0.78, 1.21 Decision Support 1.10 0.75, 1.63 Delivery System 1.38* 1.40, 1.67 Clin Info System 0.58* 0.42, 0.81

HLM Final Model Predictor O.R. 95%C.I. Female 0.59 0.36, 0.98 All Maintenance 1.82 1.08, 4.07 Comm Linkages 1.56 1.23, 1.98 Delivery System 1.47 1.17, 1.86 Clin Info System 0.58 0.44, 0.73

Conclusions Control of CVD risk factors among patients with T2DM is associated with structural characteristics of primary care clinic: Community Linkages Delivery System Design Clinical Information Systems

Community Linkages Linking clinicians to diabetes specialists and educators Patient diabetes education resources Coordinates implementation of diabetes care guidelines with assessment/treatment by specialists

Delivery System Design Practice Team Functioning Practice Team Leadership Appointment System Follow-up Planned Visits for diabetes care Continuity and Coordination of Care

Clinical Information Systems Inversely associated with CVD risk factor: Diabetes registry Reminders to providers Feedback on performance Identification of patients needing attention Patient treatment plans CIS may improve measurement of risk factors but not efforts to control Implementation of CIS may distract from risk factor control

Limitations Small number of primary care clinics Cross-sectional data Selection bias of consecutive patients Bias toward worse control of CVD risks Greater burden of illness Worse overall health status

Current/Future Research* Organizational Intervention in Primary Care Clinics to improve risk factor control Primary care clinics are complex adaptive systems with non-linear dynamic behavior No “one-size-fits-all” approach to improving risk factors Facilitation of organizational change with a focus on inter-dependence among agents See Poster by Leykum et al this afternoon *Funded by NIH/NIDDK 1 R34 DK067300-01

Acknowledgements Supported by: Agency for Healthcare Research and Quality (Grant #K08 HS013008) South Texas Health Research Center Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs. The views expressed are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs